Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00562341

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels, Testosterone, Estrogen and Other Serum Markers

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Maimonides Medical Center · Academic / Other
Sex
Male
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The proposed prospective study aims to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. If PSA levels are found to rise after weight loss, interpretation of PSA levels in morbidly obese men may be improved by upward correction of the PSA level. A 'correction factor' may be proposed for the interpretation of PSA levels in obese men, toward the clinical decision regarding indication for prostate biopsy.

Detailed description

The main objective of this study is to determine whether interpretation of PSA levels in morbidly obese men require correction due to the obesity itself. Secondary outcome measures that will be followed include the affect of obesity and weight loss on testosterone, estradiol and leptin. In as much as these might also affect PSA, we will be measuring these values as well. Also, we do not know the effects of lap-band induced weight loss on clinical outcome measures of sexual, bowel and urinary function. Thus we will aim to investigate these parameters as well.

Conditions

Interventions

TypeNameDescription
OTHERBariatric Surgeryone time lapb-band gastric bypass surgery

Timeline

Start date
2007-11-01
Primary completion
2009-12-31
Completion
2009-12-31
First posted
2007-11-22
Last updated
2018-08-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00562341. Inclusion in this directory is not an endorsement.

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels (NCT00562341) · Clinical Trials Directory